Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gamida Cell Ltd GMDAQ

Healthcare Biotechnology
Gamida Cell Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology toto expand multiple cell types including stem cells and natural killer (NK) cells while maintaining their original phenotype and... see more

Recent & Breaking News (OTCPK:GMDAQ)

XORTX Welcomes New Member to the Board of Directors

GlobeNewswire April 8, 2024

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

GlobeNewswire April 1, 2024

Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management

GlobeNewswire March 27, 2024

Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update

GlobeNewswire March 27, 2024

Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire March 22, 2024

Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

GlobeNewswire February 23, 2024

Gamida Cell Actively Pursuing Strategic Alternatives

GlobeNewswire January 29, 2024

Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

GlobeNewswire January 17, 2024

Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023

GlobeNewswire November 27, 2023

Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire November 20, 2023

Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update

GlobeNewswire November 14, 2023

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire November 4, 2023

Gamida Cell to Report Third Quarter 2023 Financial Results

GlobeNewswire November 1, 2023

Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201

Business Wire October 16, 2023

Gamida Cell Issues Update on Israel Operations

Business Wire October 9, 2023

Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa

Business Wire October 2, 2023

Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting

Business Wire September 28, 2023

First Patient Receives Gamida Cell's Omisirge(TM) (omidubicel-onlv)

Business Wire September 27, 2023

Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference

Business Wire August 31, 2023

Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update

Business Wire August 14, 2023